Tom Solomon
University of Liverpool
OutbreakInternal medicineSurgeryVirologyNeurologyIntensive care medicinePediatricsCohort studyImmunologyVirusDiseaseJapanese encephalitisCerebrospinal fluidViral encephalitisFlavivirusMeningitisDengue feverMedicineEncephalitisBiology
413Publications
76H-index
16.3kCitations
Publications 425
Newest
#1Anne-Marie Martindale (University of Liverpool)H-Index: 5
#2Caitlin Pilbeam (University of Oxford)H-Index: 2
Last. Sally Sheard (University of Liverpool)H-Index: 9
view all 10 authors...
BACKGROUND: As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning abo...
Source
#1Shubham Misra (AIIMS: All India Institute of Medical Sciences)H-Index: 10
#2Kavitha Kolappa (WHO: World Health Organization)H-Index: 1
Last. K. Prasad (Rajendra Institute of Medical Sciences)H-Index: 3
view all 23 authors...
Background and Objectives: null One year since the onset of the COVID-19 pandemic, we aimed to summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality. null Methods: null We searched PubMed, Medline, Cochrane library, clinicaltrials.gov and EMBASE from 31st December 2019 to 15th December 2020 for studies enrolling consecutive COVID-19 patients presenting with neurological mani...
Source
Source
#1Sara Dada (UCD: University College Dublin)H-Index: 6
#2Heather T. Battles (University of Auckland)H-Index: 4
Last. Nina Gobat (University of Oxford)H-Index: 11
view all 6 authors...
In responding to the widespread impacts of the COVID-19 pandemic, countries have proposed and implemented documentation policies that confer varying levels of freedoms or restrictions (e.g., ability to travel) based on individuals’ infection status or potential immunity. Most discussions around immunity- or infection-based documentation policies have focused on scientific plausibility, economic benefit, and challenges relating to ethics and equity. As COVID-19 vaccines are rolled out, attention ...
Source
#2Arina Tamborska (NIHR: National Institute for Health Research)H-Index: 1
Summary null Background null A new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous thrombosis is the most common manifestation of this syndrome but, to our knowledge, has not previously been described in detail. We aimed to document the features of post-vaccination cerebral venous thrombosis with and without VITT and to assess whether VITT is associated with poorer outcomes. null Methods null...
Source
#1Stephen Ray (Malawi-Liverpool-Wellcome Trust Clinical Research Programme)H-Index: 4
#2Omar Abdel-Mannan (UCL Institute of Neurology)H-Index: 2
Summary null null Background null The spectrum of neurological and psychiatric complications associated with paediatric SARS-CoV-2 infection is poorly understood. We aimed to analyse the range and prevalence of these complications in hospitalised children and adolescents. null null null Methods null We did a prospective national cohort study in the UK using an online network of secure rapid-response notification portals established by the CoroNerve study group. Paediatric neurologists were invit...
Source
#2Arina Tamborska (NIHR: National Institute for Health Research)H-Index: 1
#4Emily N. McNeill (NewYork–Presbyterian Hospital)
Last. Imo Akpan (NewYork–Presbyterian Hospital)H-Index: 1
view all 21 authors...
Abstract null null Background null Vaccine induced immune medicated thrombocytopenia or VITT, is a recent and rare phenomenon of thrombosis with thrombocytopenia, frequently including cerebral venous thromboses (CVT), that has been described following vaccination with adenovirus vaccines ChAdOx1 nCOV-19 (AstraZeneca) and Ad26.COV2·S Johnson and Johnson (Janssen/J&J). The evaluation and management of suspected cases of CVT post COVID-19 vaccination are critical skills for a broad range of healthc...
Source
#1Laura A. BenjaminH-Index: 22
#2Ross W. PatersonH-Index: 27
Last. Anna M. Checkley (UCL: University College London)H-Index: 4
view all 36 authors...
Background A high prevalence of antiphospholipid antibodies has been reported in case series of patients with neurological manifestations and COVID-19; however, the pathogenicity of antiphospholipid antibodies in COVID-19 neurology remains unclear. Methods This single-centre cross-sectional study included 106 adult patients: 30 hospitalised COVID-neurological cases, 47 non-neurological COVID-hospitalised controls, and 29 COVID-non-hospitalised controls, recruited between March and July 2020. We ...
Source
#1Vaselli Nm (University of Liverpool)H-Index: 3
#2Wega Setiabudi (University of Liverpool)H-Index: 2
Last. Daniel Hungerford (University of Liverpool)H-Index: 12
view all 10 authors...
Background null SARS-CoV-2 is frequently shed in the stool of patients hospitalised with COVID-19. The extent of faecal shedding of SARS-CoV-2 among individuals in the community, and its potential to contribute to spread of disease, is unknown. null Methods null In this prospective, observational cohort study among households in Liverpool, UK, participants underwent weekly nasal/throat swabbing to detect SARS-CoV-2 virus, over a 12-week period from enrolment starting July 2020. Participants that...
Source
#1Matthew ButlerH-Index: 6
#2Arina Tamborska (Walton Centre)H-Index: 1
Last. Thomas A Pollak ('KCL': King's College London)H-Index: 21
view all 12 authors...
Worldwide SARS-CoV-2 vaccination campaigns for prevention of COVID-19 are currently underway. In clinical trials and in open-label monitoring the vaccines have shown efficacy against COVID-19 and there have been limited and transient side effects. Previous vaccination campaigns have taught us that neurological adverse events to vaccinations can occur. In this review, we summarise what is already known about neurological and neuropsychiatric adverse events of COVID-19 vaccinations, and place this...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.